Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? (2007)

  • Authors:
  • USP affiliated authors: TAKAHASHI, WALTER YUKIHIKO - FM ; LAURINDO, IEDA MARIA MAGALHAES - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s10067-006-0478-9
  • Subjects: ARTRITE REUMATOIDE; MÁCULA LÚTEA (PATOLOGIA); FATORES DE RISCO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10067-006-0478-9 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Clinical Rheumatology

    ISSN: 0770-3198

    Citescore - 2017: 2.04

    SJR - 2017: 0.93

    SNIP - 2017: 0.877


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700089688-SFM BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SHINJO, Samuel K.; MAIA JUNIOR, Otacílio O.; TIZZIANI, Vivian A. P.; et al. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clinical Rheumatology, Brussels, v. 26, n. 8, p. 1248-1253, 2007. DOI: 10.1007/s10067-006-0478-9.
    • APA

      Shinjo, S. K., Maia Junior, O. O., Tizziani, V. A. P., Morita, C., Kochen, J. A. L., Takahashi, W. Y., & Laurindo, I. M. M. (2007). Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clinical Rheumatology, 26( 8), 1248-1253. doi:10.1007/s10067-006-0478-9
    • NLM

      Shinjo SK, Maia Junior OO, Tizziani VAP, Morita C, Kochen JAL, Takahashi WY, Laurindo IMM. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clinical Rheumatology. 2007 ; 26( 8): 1248-1253.
    • Vancouver

      Shinjo SK, Maia Junior OO, Tizziani VAP, Morita C, Kochen JAL, Takahashi WY, Laurindo IMM. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clinical Rheumatology. 2007 ; 26( 8): 1248-1253.

    Referências citadas na obra
    Fox RI, Dixon R, Guarrasi V, Krubel S (1996) Treatment of primary Sjögren’s syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5:S31–S36
    Meinao IM, Sato EI, Andrade LEC, Ferraz MB, Atra E (1996) Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus 5:237–241
    Olson NY, Lindsley CB (1986) Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 16:1545–1547
    Ryes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36:799–805
    Weinberg DV, D’Amico DJ (1994) Retinal toxicity of systemic drugs. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology: clinical practice. Saunders, Philadelphia, pp 3284–3285
    Cambiaggi A (1957) Unusual ocular lesions in a case of systemic lupus erythematosus. Arch Ophthalmol 57:451–457
    Bernstein H, Zvaifler N, Rubin M, Mansour AM (1963) The ocular deposition of chloroquine. Invest Ophthalmol 2:384–392
    Easterbrook M (1987) Dose relationships in patients with early chloroquine retinopathy. J Rheumatol 14:472–475
    Henkind P, Rothfield NF (1963) Ocular abnormalities in patients treated with synthetic antimalarial drugs. N Engl J Med 269:433–439
    Cox NH, Paterson WD (1994) Ocular toxicity of antimalarial in dermatology: a survey of current practice. Br J Dermatol 131:878–882
    Finbloom DS, Silver K, Newsome DA, Gunkel R (1985) Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 12:692–694
    Bernstein HN (1983) Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 75:25–34
    Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF; American Academy of Ophthalmology (2002) Recommendations of screening for chloroquine and hydroxychloroquine retinopathy. A Report by the American Academy of Ophthalmology. Ophthalmology 109:1377–1382
    Arnett FX, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang SR, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DII, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
    Easterbrook M (1992) Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 27:237–239
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychlroquine: a reappraisal. Ophthalmology 110:1321–1326
    Wei LC, Chen SN, Ho CL, Kuo YH, Ho JD (2001) Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report. Chang Gung Med J 24:329–334
    Sassani JW, Brucker AJ, Cobbs W, Campbell C (1983) Progressive chloroquine retinopathy. Ann Ophthalmol 15:19–22
    Bernstein H, Zvaifler N, Rubin M, Mansour AM (1963) The ocular deposition of chloroquine. Invest Ophthalmol 2:384–392
    Henkind P, Rothfield NF (1963) Ocular abnormalities in patients treated with synthetic antimalarial drugs. N Engl J Med 269:433–439
    Cursiefen C, Grunert U, Junemann A (1997) Chloroquine-induced bull´s eye maculopathy without electrophysiologic changes. Klin Monatsbl Augenheilkd 210:400–401
    Inada ET, Watanabe KP, Tanaka SG, Sakakisbara LA (2005) Ocular toxicity caused by chloroquine: case report. Arq Bras Oftalmol 68:407–409
    Lai WW, Lam DS (2005) Chloroquine-induced bull’s eye maculopathy. Hong Kong Med J 11:55–57
    Rynes RI, Krohel G, Falbo A, Reineck RD, Wolfe B, Bartholomew LE (1979) Ophthalmologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum 22:833–836
    Tobin D, Krohel G, Rynes RI (1982) Hydroxychloroquine, seven-year experience. Arch Ophthalmol 100:81–83
    Araiza-Casillas R, Cárdenas F, Morales Y, Cardiel MH (2004) Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus 13:119–124
    Dubois EL (1978) Antimalarial in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 8:33–51
    Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (2004) Kelly’s textbook of rheumatology, 7th edn, vol I, Section VIII
    Scherbel AL, Mackenzie, AH, Nousek JE, Atdjian M (1965) Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. N Engl J Med 273:360–366
    Elman A, Gullberg R, Nilsson E, Rendahl I, Wachtmeister L (1976) Chloroquine retinopathy in patients with rheumatoid arthritis. Scand J Rheumatol 5:161–166
    Marks JS (1982) Chloroquine retinopathy: is there a safe daily dose? Ann Rheum Dis 41:52–58
    Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 75:40–45
    Cruess AF, Schachat AP, Nicholl J, Augsburger JJ (1985) Chloroquine retinopathy. Is fluorescein angiography necessary? Ophthalmology 92:1127–1129
    Easterbrook M (1998) Current concepts in monitoring patients on antimalarials (Editorial). Aust N Z J Ophthalmol 26:101–103
    Mavrikakis M, Papazoglou S, Sfikakis PP, Vaiopoulos G, Rougas K (1996) Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 55:187–189
    Weise EE, Yannuzzi LA (1974) Ring maculopathies mimicking chloroquine retinopathy. Am J Ophthalmol 78:204–210
    Sutter EE, Tran D (1992) The field topography of ERG components in man. I The photopic luminance response. Vision Res 32:433–436
    Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23:503–512
    Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108:87–97
    Kellner U, Kraus H, Foerster MH (2000) The multifocal electroretinogram can detect retinal dysfunction in chloroquine retinopathy even when the full-field electroretinogram is normal and retinal alteration is subtle. Graefes Arch Clin Exp Ophthalmol 238:94–97